POSIPHEN

posiphen · Annovis Bio Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for POSIPHEN, covering 2015-04-22 to 2023-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease [Phase 1, Phase 2]